TriSalus Life Sciences TLSI
NASDAQ TLSI
$4.29 +0.14 (+3.37%)
As of: Oct 2, 2026 · 11:36 AM EDT

TriSalus Life Sciences (TLSI) Return on Equity [ROE] (2026)

Updated

TriSalus Life Sciences' Return on Equity [ROE] came in at -291.49% for Q2 2026.

Analysis

TriSalus Life Sciences (TLSI) Return on Equity [ROE] (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 10.39%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 17.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 10.44%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -3.90%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 14.31%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 9.53%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 3.88%
10 TriSalus Life Sciences 264.93 Mn 118.97 Mn 9.90 Mn -291.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -291.49%
API Access

TriSalus Life Sciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TLSI&period=max&api_key=YOUR_API_KEY